Prolonged urticaria with 17-1A antibody

British Medical Journal

Volumn 317, Issue 7173, 1998, Pages 1631-

  Sizmann, N ^a   Korting, H C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; URTICARIA;

ADENOCARCINOMA; AGED; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; DRUG ERUPTIONS; FEMALE; HUMANS; URTICARIA;

EID: 0032512292     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Haller DG. An overview of adjuvant therapy for colorectal cancer. Eur J Cancer 1995;31A:1255-63.
2. Riethmüller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hollken K, et al. Randomised nial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994;343:1177-83.
3. LoBuglio AF, Wheeler RH, Trang K, Haynes A, Rogers K, Harvey EB, et al. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci 1989;8G:4220-4.
4. Fagerberg J, Ragnhammar P, Liljefors M, Hjelm A-L, Mellstedt H, Frodin J-L. Humoral antiiidiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A. Cancer Immunol Immunother 1985;42:81-7.
5. Fagerberg J, Steinitz M, Wigzell H, Askelof P, Mellstedt H. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma associated antigen in patients. Proc Natl Acad Sci 1995;92:4773-7.